This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Epic Sciences Inc. raised $52mm through its Series E round led by Blue Ox Healthcare Partners. Deerfield Management and Varian also participated, along with existing investors Altos Capital Partners, Genomic Health, Domain Associates, VI Ventures, Alexandria Venture Investments, and Sabby Management. Epic is developing molecular diagnostics for cancer and will use the Series E money to advance development of its predictive tests designed with the company's No Cell Left Behind platform.
In Vitro Diagnostics
Molecular Diagnostics & Genetic Testing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?